These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 19942848)

  • 21. Resistant hypertension-defining the scope of the problem.
    Chia R; Pandey A; Vongpatanasin W
    Prog Cardiovasc Dis; 2020; 63(1):46-50. PubMed ID: 31863785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence.
    Grigoryan L; Pavlik VN; Hyman DJ
    J Am Soc Hypertens; 2013; 7(6):471-6. PubMed ID: 23890931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability.
    Carter BL; Ernst ME; Cohen JD
    Hypertension; 2004 Jan; 43(1):4-9. PubMed ID: 14638621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of blood pressure in patients with treatment-resistant hypertension.
    Acelajado MC; Calhoun DA; Oparil S
    Expert Opin Pharmacother; 2009 Dec; 10(18):2959-71. PubMed ID: 19925047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of chlorthalidone and hydrochlorothiazide in combination with amiloride in multiple doses on blood pressure in patients with primary hypertension: a protocol for a factorial randomized controlled trial.
    Martins VM; Helal L; Ferrari F; Bottino LG; Fuchs SC; Fuchs FD
    Trials; 2019 Dec; 20(1):736. PubMed ID: 31843024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Module 3: Using thiazide-type diuretics in African Americans with hypertension.
    Wright JT
    J Fam Pract; 2012 Aug; 61(8 Suppl):S20-2; quiz S31. PubMed ID: 22993738
    [No Abstract]   [Full Text] [Related]  

  • 28. [Resistant hypertension: An update].
    Renna NF
    Hipertens Riesgo Vasc; 2019; 36(1):44-52. PubMed ID: 29397348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistant hypertension: patient characteristics, risk factors, co-morbidities and outcomes.
    Oliveras A; de la Sierra A
    J Hum Hypertens; 2014 Apr; 28(4):213-7. PubMed ID: 23985879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Resistant and Refractory Hypertension.
    Acelajado MC; Hughes ZH; Oparil S; Calhoun DA
    Circ Res; 2019 Mar; 124(7):1061-1070. PubMed ID: 30920924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of essential arterial hypertension].
    Girerd X
    Presse Med; 2000 Nov; 29(34):1856-8. PubMed ID: 11709818
    [No Abstract]   [Full Text] [Related]  

  • 32. Update on diagnosis and treatment of resistant hypertension.
    Pimenta E
    Iran J Kidney Dis; 2011 Jul; 5(4):215-27. PubMed ID: 21725176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistant hypertension in an obese patient with obvious obstructive sleep apnea and occult pheochromocytoma.
    Szymanski FM; Karpinski G; Hrynkiewicz-Szymanska A; Filipiak KJ
    Can J Cardiol; 2012 May; 28(3):397.e5-7. PubMed ID: 22281411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertension.
    Winter KH; Tuttle LA; Viera AJ
    Prim Care; 2013 Mar; 40(1):179-94. PubMed ID: 23402468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistant hypertension: an overview.
    McAlister FA; Lewanczuk RZ; Teo KK
    Can J Cardiol; 1996 Sep; 12(9):822-8. PubMed ID: 8842136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approaches for the Management of Resistant Hypertension in 2020.
    Aronow WS
    Curr Hypertens Rep; 2020 Jan; 22(1):3. PubMed ID: 31916065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Hackam DG; Khan NA; Hemmelgarn BR; Rabkin SW; Touyz RM; Campbell NR; Padwal R; Campbell TS; Lindsay MP; Hill MD; Quinn RR; Mahon JL; Herman RJ; Schiffrin EL; Ruzicka M; Larochelle P; Feldman RD; Lebel M; Poirier L; Arnold JM; Moe GW; Howlett JG; Trudeau L; Bacon SL; Petrella RJ; Milot A; Stone JA; Drouin D; Boulanger JM; Sharma M; Hamet P; Fodor G; Dresser GK; Carruthers SG; Pylypchuk G; Burgess ED; Burns KD; Vallée M; Prasad GV; Gilbert RE; Leiter LA; Jones C; Ogilvie RI; Woo V; McFarlane PA; Hegele RA; Tobe SW;
    Can J Cardiol; 2010 May; 26(5):249-58. PubMed ID: 20485689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistant hypertension: identifying causes and optimizing treatment regimens.
    Trewet CL; Ernst ME
    South Med J; 2008 Feb; 101(2):166-73. PubMed ID: 18364619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary hypertension, issues in diagnosis and treatment.
    Pullalarevu R; Akbar G; Teehan G
    Prim Care; 2014 Dec; 41(4):749-64. PubMed ID: 25439532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of difficult-to-control hypertension.
    Graves JW
    Mayo Clin Proc; 2000 Mar; 75(3):278-84. PubMed ID: 10725955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.